Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Share News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
554.00    0.50 (0.09%)
Bid:
554.00
Ask:
554.50
Spread: 0.50 (0.09%)
Market Cap: £2.45b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Tate & Lyle sees improved demand as lockdowns ease

Thu, 23rd Jul 2020 08:38
(Sharecast News) - Food and beverage ingredients group Tate & Lyle saw demand for its product improve during June as global coronavirus-related lockdowns began to ease.
Tate & Lyle said while its performance in the first quarter reflected the impact of lockdowns on out-of-home consumption in North America and Europe, this had been partially offset by resilience from in-home consumption during the period.

The FTSE 250-listed outfit said fluctuating demand patterns in April and May had improved in both its in and out-of-home divisions in June as lockdowns started to ease. However, it cautioned the full extent of the pandemic's impact still remained unclear.

For the three months to June ended 30, food and beverage revenues were up 1% at £232m, while volume was 2% lower as reduced demand for ingredients used in food and drink consumed out-of-home outweighed stronger demand for packaged and shelf-stable foods for consumption in-home. Suraclose revenues were down 1% at £39m, while primary products revenues were 9% lower at £420m.

Chief executive Nick Hampton said: "As expected, the first quarter presented many challenges and I am very proud of the way we are navigating the impact of Covid-19. Our new business pipeline is healthy, we continue to find creative ways to use technology to support and connect with our customers, and all our manufacturing facilities remain fully operational. "

As of 0845 BST, Tate & Lyle shares were up 2.79% at 670.80p.

Related News

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
9 Jun 2026

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
9 Jun 2026

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...

Tate & Lyle News

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
9 Jun 2026

LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
9 Jun 2026

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...

UK's FTSE 100 recovers from lows as Israel and Iran halt strikes on each other
8 Jun 2026

UK's FTSE 100 recovers from lows as Israel and Iran halt strikes on each other

June 8 (Reuters) - UK's FTSE 100 ended flat on Monday, well off its ​session ‌lows as oil prices eased a touch after Iran and Israel said they would s...

LONDON MARKET CLOSE: Stocks mixed amid lack of Middle East progress
8 Jun 2026

LONDON MARKET CLOSE: Stocks mixed amid lack of Middle East progress

(Alliance News) - The FTSE 100 edged higher on Monday on a mixed day for stocks in London, as US markets recouped some of Friday's hefty falls and inv...

LONDON MARKET MIDDAY: FTSE 100 recovers despite intensifying Iran war
8 Jun 2026

LONDON MARKET MIDDAY: FTSE 100 recovers despite intensifying Iran war

(Alliance News) - Stock prices in London were mixed at midday on Monday, as the FTSE 100 recovered from earlier losses, with investors rattled by rene...

WINNERS & LOSERS: Housebuilders, airlines fall on Middle East flare-up
8 Jun 2026

WINNERS & LOSERS: Housebuilders, airlines fall on Middle East flare-up

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday.

Ingredion to buy UK's Tate & Lyle for $3.6 billion
8 Jun 2026

Ingredion to buy UK's Tate & Lyle for $3.6 billion

* Deal values Tate & Lyle at £3.8 billion including ​debt